SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-026640
Filing Date
2024-07-09
Accepted
2024-07-09 16:30:12
Documents
14
Period of Report
2024-07-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42868
2 ex3-1.htm EX-3.1 118015
  Complete submission text file 0001493152-24-026640.txt   362254

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abeo-20240705.xsd EX-101.SCH 3045
4 XBRL LABEL FILE abeo-20240705_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abeo-20240705_pre.xml EX-101.PRE 22379
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3799
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 241107757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)